INSIGHTS ON LIQUID DOSE MANUFACTURING

• Host Cell Impurities, Bioassays, Micro-Flow Imaging

  Ensuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.

• Navigating The New USP Chapter <382> For Elastomeric Closures

  Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.

• Bridging The Gap Between Product Readiness And Equipment Availability

  Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.

• Accelerating Sterile Injectable Innovation Through Strategic Outsourcing

  Sterile injectables are vital for modern medicine. Learn how outsourcing manufacturing to a CDMO can accelerate development and commercialization.

• Compressed Gas Systems In Aseptic Manufacturing

  10/18/2024

  Learn about compressed gas systems and why effectively identifying and managing the risks associated with these systems is critical for maintaining product quality and ensuring compliance with GMP.

• Shaping The Future Of ATMPs: Tailored Automation And Advanced Technologies For The Next Decade

  3/27/2025

  From personalized treatments to large-scale viral vector production, the future of ATMPs hinges on optimized automation. We delve into the technologies driving this transformation and the challenges ahead.

• Navigating Your Holistic Approach To CCI For Biologic Drug Products

  6/12/2024

  Explore regulatory framework and expectations, and see the benefit of a comprehensive approach to CCI tailored for mAbs and complex modalities such as fusion proteins or bioconjugates.

• Compressed Gas Contamination: Guidelines For Control In Aseptic Manufacturing

  10/18/2024

  Explore key guidelines for preserving the purity and quality of compressed gas, with an emphasis on contaminants, monitoring, and preventive maintenance practices.

• CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics

  4/28/2025

  CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.